# FDA 483 - Adaptimmune LLC - April 05, 2024

Source: https://www.globalkeysolutions.net/records/483/adaptimmune-llc/3acfddd4-65a3-42ea-886c-a7887509cfaf

> FDA 483 for Adaptimmune LLC on April 05, 2024. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Adaptimmune LLC
- Inspection Date: 2024-04-05
- Product Type: biologics
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Officers

- [Elvia Angus, CSO](https://www.globalkeysolutions.net/people/elvia-angus-cso/06ce9fc4-b58d-49bf-8274-0612f95a0ed0)
- [Viviana Ramirez](https://www.globalkeysolutions.net/people/viviana-ramirez/1d34f713-edc8-4776-ad70-28fcd59345de)
- [investigator](https://www.globalkeysolutions.net/people/anna-r-kwilas/c5c90f89-83e2-48a3-9ce7-efc7c9519d9f)

Company: https://www.globalkeysolutions.net/companies/adaptimmune-llc/6394510c-b8e5-4662-a4f9-e3f788e5adcb

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd